Proportion of participants who were medication‐free (not using drops) at 12 months · people with open‐angle glaucoma
It is very uncertain whether phaco‐AIT changes proportion of participants who were medication‐free (not using… compared with phaco‐Trab (very low certainty).
1 finding from 1 review
Proportion of participants who were medication‐free (not using eye drops) medium‐term · people with open‐angle glaucoma
Phacoemulsification + supraciliary microstent surgery probably leads to higher proportion of participants who were medication‐free (not using… compared with phacoemulsification alone (moderate certainty).
1 finding from 1 review
Mean change in daily IOP‐lowering medicationsat 24 months (medium‐term) · people with open‐angle glaucoma
Phacoemulsification + supraciliary microstent surgery showed no clear difference in mean change in daily IOP‐lowering medicationsat 24 months… compared with phacoemulsification alone (moderate certainty).
1 finding from 1 review
Use of IOP‐lowering medications ‐ 24 months · macular edema in diabetes
Intravitreal dexamethasone implant 0.7 mg probably leads to higher use of IOP‐lowering medications ‐ 24 months compared with intravitreal antiVEGF (moderate certainty).
1 finding from 1 review
RR 4.76 [2.84, 7.99]
Studies not reported
Moderate
Use of IOP‐lowering medications ‐ 24 months · macular edema in diabetes
Intravitreal fluocinolone acetonide implant 0.19 mg probably leads to higher use of IOP‐lowering medications ‐ 24 months compared with sham (moderate certainty).
1 finding from 1 review
Use of IOP‐lowering medications ‐ 24 months · macular edema in diabetes
It is very uncertain whether intravitreal triamcinolone acetonide injection 4 mg changes use of IOP‐lowering medications ‐ 24 months compared with sham (very low certainty).
1 finding from 1 review
RR 21.6 [1.32, 354.7]
Studies not reported
Very low
Use of IOP‐lowering medications · macular edema in diabetes
Intravitreal triamcinolone acetonide injection 4 mg probably leads to higher use of IOP‐lowering medications ‐ 9 to 24 months compared with macular laser (moderate certainty).
1 finding from 1 review
RR 3.92 [2.59, 5.96]
Studies not reported
Moderate
Use of IOP‐lowering medications · macular edema in diabetes
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Use of IOP‐lowering medications · macular edema in diabetes
Intravitreal dexamethasone implant 0.7 mg probably leads to higher use of IOP‐lowering medications ‐ 36 months compared with sham (moderate certainty).
1 finding from 1 review
Proportion of participants with IOP≤ 21 mmHg, with or without ocular hypotensive medications 1 year · children at or before five years of age with primary congenital glaucoma
It is very uncertain whether combined trabeculotomy with trabeculectomy changes surgical success: proportion with postoperative IOP ≤ 21 mmHg with… compared with trabeculotomy (very low certainty).
1 finding from 1 review
Proportion with postoperative IOP ≤ 21 mmHg (surgical success) with or without glaucoma medications 6 months after surgery · children at or before five years of age with primary congenital glaucoma
It is very uncertain whether viscotrabeculotomy changes proportion with postoperative IOP ≤ 21 mmHg (surgical success) with… compared with conventional trabeculotomy (very low certainty).
1 finding from 1 review
Proportion of participants with IOP≤ 21 mmHg, with or without ocular hypotensive medications 1 year · children at or before five years of age with primary congenital glaucoma
Microcatheter‐assisted trabeculotomy probably leads to higher proportion with postoperative IOP ≤ 21 mmHg (surgical success) with… compared with conventional trabeculotomy (moderate certainty).
1 finding from 1 review
Mean number of antiglaucoma medications at 1‐year · adults with refractory glaucoma
1 finding from 1 review
Intervention not reported
Mean number of glaucoma medications 12 months postintervention · adults with refractory glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Mean number of glaucoma medications 12 months postintervention · adults with refractory glaucoma
1 finding from 1 review
Mean number of antiglaucoma medications at 1‐year · adults with refractory glaucoma
1 finding from 1 review
Mean number of antiglaucoma medications at 1‐year · people with primary open‐angle glaucoma and no previous glaucoma surgery
1 finding from 1 review
Mean number of antiglaucoma medications at 1‐year · People with glaucoma
Ahmed implant probably leads to higher mean number of antiglaucoma medications at 1‐year compared with baerveldt implant (moderate certainty).
1 finding from 1 review
Mean number of antiglaucoma medications at 1‐year · People with glaucoma
Ahmed implant showed no clear difference in mean number of antiglaucoma medications at 1‐year compared with molteno implant (low certainty).
1 finding from 1 review
Mean number of antiglaucoma medications at 1‐year · People with glaucoma
The review found no eligible studies for this question.
1 finding from 1 review